Millipore expands drug development facilties
This article was originally published in Scrip
Executive Summary
Millipore, a US-based biopharmaceutical manufacturing company, will expand its drug discovery facility in St Charles, Missouri. The $3.4 million expansion will see the company hire an additional 60 employees to add to the 187 that already work at the St Charles facility. Millipore is seeking certification from the Leadership in Energy and Environmental Design (LEED) green building rating system for the expanded 17,000sq ft space, where it will build new laboratories, administrative offices and an enlarged break area. In 2006, Millipore acquired Serologicals Corporation for $1.4 billion, which itself had previously acquired Cytomyx, one of the industry's largest suppliers of ion channel cell lines (ScripNo 3155, p 14).